Collection: Hidradenitis Suppurativa Collection
-
Safety Shield Study for ADALIMUMAB
Regular price From β¬800,00 EURRegular priceUnit price / per -
Clinical Endpoints Study for HIDRADENITIS SUPPURATIVA
Regular price From β¬2.000,00 EURRegular priceUnit price / per -
Expert mapping Study for HIDRADENITIS SUPPURATIVA
Regular price From β¬1.500,00 EURRegular priceUnit price / per -
Safety Shield Study for RESLIZUMAB
Regular price From β¬800,00 EURRegular priceUnit price / per -
Safety Shield Study for METFORMIN
Regular price From β¬800,00 EURRegular priceUnit price / per -
Safety Shield Study for ANAKINRA
Regular price From β¬800,00 EURRegular priceUnit price / per -
Safety Shield Study for USTEKINUMAB
Regular price From β¬800,00 EURRegular priceUnit price / per -
Safety Shield Study for SECUKINUMAB
Regular price From β¬800,00 EURRegular priceUnit price / per -
Safety Shield Study for INFLIXIMAB
Regular price From β¬800,00 EURRegular priceUnit price / per -
Safety Shield Study for BRODALUMAB
Regular price From β¬800,00 EURRegular priceUnit price / per -
Safety Shield Study for DAPSONE
Regular price From β¬800,00 EURRegular priceUnit price / per -
Safety Shield Study for TETRACYCLINE
Regular price From β¬800,00 EURRegular priceUnit price / per -
Safety Shield Study for CLINDAMYCIN
Regular price From β¬800,00 EURRegular priceUnit price / per -
Safety Shield Study for MINOCYCLINE
Regular price From β¬800,00 EURRegular priceUnit price / per
Explore our exclusive study series
-
Safety Shield Studies
Safety Shield uses AI to streamline pharmacovigilance, reducing specialist workload by 80%...
-
Expert Mapping Studies
Expert Mapping Reports cut screening time by 10 days and reduce failed...
-
Clinical Endpoints Studies
This targeted analysis delivers a robust assessment of clinical endpoints tailored to...